Medicaid

State Medicaid agencies are working to provide comprehensive health care services for children with autism spectrum disorder (ASD), currently the fastest growing developmental disability in the United States for individuals under age 21. This brief highlights information from the 2014 CMS Informational Bulletin providing clarification on services to be provided to Medicaid-eligible children with ASD […]

Read More
  • State Legislative Action on Pharmaceutical Prices
    Maps

    *Updated March 15, 2017* As part of our Pharmacy Cost Work Group, an ongoing project that looks beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of prescription drug costs, NASHP has been tracking state legislative actions to control the rising cost of prescription drugs. This series […]

    Read More
  • Publications

    A Primer on Opportunities for Medicaid-Safety Net Collaboration The prevalence of substance abuse disorders in the United States has increased dramatically in the past 15 years with catastrophic consequences, especially in rural regions of the United States. Deaths and injuries from illegal opioid and heroin use are more prevalent in rural states, and death from […]

    Read More
    September 12, 2016 | Filed under: Behavioral Health, Front Page, Medicaid, National, North Carolina, Publications
  • The high prevalence of uncontrolled asthma among child populations served by Medicaid programs and the associated rising costs often are the impetus for states to improve the quality of care provided to children with asthma. New opportunities to comprehensively address asthma and its triggers are emerging through state and national health care delivery system and […]

    Read More
  • Publications

    The early years of a child’s life are critical for growth and development. Identifying developmental delays early and providing appropriate referral and treatment can help prevent more severe issues as well as considerable costs. State Medicaid agencies can play an important role in promoting early identification of developmental delays by reimbursing and tracking the use […]

    Read More
  • Publications

    Although most Medicaid agencies cover services that can be used as alternatives to opioids for pain management, significantly fewer states have policies or procedures in place to encourage their use. Between March and June 2016, the National Academy for State Health Policy (NASHP) conducted a survey of all 51 Medicaid agencies to determine the extent […]

    Read More
    September 2, 2016 | Filed under: Front Page, Long Term and Chronic Care, Medicaid, Publications
  • NASHP has written two case studies for HealthHIV’s Three D HIV Prevention Program, which is supported by the Centers for Disease Control and Prevention (CDC), and provides technical assistance to better inform programmatic decisions impacting the delivery of quality HIV prevention and treatment services: New York’s experience implementing performance metrics for the HIV/AIDS population in its Medicaid managed […]

    Read More
  • This chart provides eligibility levels for states’ coverage of services for pregnant women under Medicaid (Title XIX of the Social Security Act) and the Children’s Health Insurance Program (Title XXI of the Social Security Act) in 2013 and 2014. Coverage levels for 2014 include states’ modified adjusted gross income (MAGI)-converted eligibility levels. Every state provides […]

    Read More
    June 3, 2016 | Filed under: Charts, Medicaid, Medicaid Benefits, National
  • Publications

    States are testing a myriad of models that strive to achieve the Triple Aim objectives of improved care, reduced health care costs, and better health. Though several statewide health care delivery and payment system reforms have been shown to help slow the growth of health care expenditures and improve methods for delivering health care, taken […]

    Read More
  • The newly launched National Academy for State Health Policy (NASHP) Pharmacy Cost Work Group will look beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of Rx costs. The group will look broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation […]

    Read More